Vimarsana
Biggest News Aggregation in the World

Citius Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Citius Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Citius Pharmaceutical Today - Breaking & Trending Today

Comparing Citius Pharmaceuticals (NASDAQ:CTXR) and GlycoMimetics (NASDAQ:GLYC) - Vimarsana News

Comparing Citius Pharmaceuticals (NASDAQ:CTXR) and GlycoMimetics (NASDAQ:GLYC)

GlycoMimetics (NASDAQ:GLYC – Get Free Report) and Citius Pharmaceuticals (NASDAQ:CTXR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Analyst Recommendations This is a summary of recent […]

Source: wkrb13.com
Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Vimarsana News

Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)

With the business potentially at an important milestone, we thought we'd take a closer look at Citius Pharmaceuticals...

Source: yahoo.com
Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Vimarsana News

Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)

Citius Pharmaceuticals, Inc. ( NASDAQ:CTXR ) is possibly approaching a major achievement in its business, so we would...

Source: yahoo.com
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) to Post FY2024 Earnings of $0.10 Per Share, HC Wainwright Forecasts - Vimarsana News

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) to Post FY2024 Earnings of $0.10 Per Share, HC Wainwright Forecasts

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Free Report) – Equities researchers at HC Wainwright raised their FY2024 earnings estimates for shares of Citius Pharmaceuticals in a report issued on Tuesday, August 1st. HC Wainwright analyst V. Bernardino now forecasts that the company will post earnings per share of $0.10 for the year, up from their previous […]

Rocket Pool ETH (RETH) Self Reported Market Cap Achieves $639.56 Million - Vimarsana News

Rocket Pool ETH (RETH) Self Reported Market Cap Achieves $639.56 Million

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Get Rating) – Investment analysts at HC Wainwright decreased their Q3 2023 earnings per share estimates for Citius Pharmaceuticals in a report issued on Tuesday, May 30th. HC Wainwright analyst V. Bernardino now forecasts that the company will earn ($0.07) per share for the quarter, down from their previous estimate […]